<DOC>
	<DOCNO>NCT01918683</DOCNO>
	<brief_summary>This trial design initial prospective pilot investigation effectiveness combine SBRT TACE bridge therapy HCC patient await liver transplanation . No prospective clinical trial regard combination TACE SBRT pre-transplant population perform . We propose trial conduct pilot clinical trial goal enrol 40 patient arm</brief_summary>
	<brief_title>TACE With Without SBRT Bridging Therapy Pre-transplant HCC Patients</brief_title>
	<detailed_description>The purpose study determine whether combination stereotatic body radiotherapy ( SBRT ) tand transarterial chemoembolization ( TACE ) effective `` bridge therapy '' patient hepatocellular carcinoma ( HCC ) liver await transplantation .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<criteria>Patient capable give informed consent Patient diagnose hepatocellular carcinoma list recommend listed orthotopic liver transplantation participate institution Age &gt; 18 year old Meets clinical criterion eligibility TACE target lesion per Interventional Radiology Childs ' Class A B7 Eastern Clinical Oncology Group performance status 0 1 Prior radiotherapy upper abdomen radioembolization liver Prior TACE target lesion , RFA , liver transplant Active GI bleed within 2 week study enrollment Active GI ulcer disease within 4 week study enrollment Ascites refractory medical therapy Contraindication receive radiotherapy TACE Complete obstruction portal venous flow segment liver include target lesion Contraindication contrast enhance MRI contrast enhance CT ( i.e . unable undergo followup image SBRT treatment planning ) Women pregnant Participation another concurrent treatment protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>